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Abstract
Vulvar squamous cell carcinoma with sarcoma-like stroma represents an extremely rare histological entity showing
the co-existence of both epithelial and mesenchymal features: these tumors, firstly described in the skin by Martin
and Stewart in 1935 have been further described in other anatomic sites including oral cavity, larynx, breast, lung
and oesophagus. The complexity of the histology, as well as its aggressive clinical behaviour makes the diagnosis
and the exploitment of effective therapeutic approaches very difficult, so that no definitive guidelines for
treatments are currently available. Here, we describe a case of advanced stage vulvar squamous cell carcinoma
with sarcoma-like stroma showing an unfavourable prognosis despite the use of an aggressive multimodal
approach. A revision of the currently published cases have been also provided.
Background
Vulvar malignancies are rare tumors accounting for
almost 4% of all gynaecological cancer, and are still con-
s i d e r e dt ob em o s t l yad i s e a s eo fo l d e rw o m e n[ 1 ] .
While squamous cell carcinoma contributes approxi-
mately to 90% of vulvar tumors, mesenchymal neopla-
sias are uncommon, and typically show an aggressive
clinical behaviour [1]. An extremely rare histological
entity is represented by vulvar malignancies showing the
co-existence of both epithelial and mesenchymal fea-
tures: these tumors, firstly described in the skin by Mar-
tin and Stewart in 1935 have been further described in
other anatomic sites including oral cavity, larynx, breast,
lung and oesophagus [2,3]. The first case of vulvar squa-
mous cell carcinoma showing the co-existence of areas
with sarcomatoid features was reported in 1983 by Stee-
per et al [4]. Since then, few other cases have been pub-
lished characterizing vulvar squamous cell carcinoma
with sarcoma-like stroma (VSCS) as an aggressive dis-
ease typically associated with early development of both
local recurrences and distant metastases [3]. The com-
plexity of the histology, as well as the aggressive clinical
behaviour makes the diagnosis and the exploitment of
effective therapeutic approaches very difficult, so that no
definitive guidelines for treatments of this malignancy
are currently available.
Here, we describe a case of VSCS highlighting the
diagnostic and clinical challenges in the context of the
available literature.
Case presentation
In August 2009, a 79-year-old woman, 3 gravida 3 para,
was admitted to the Gynaecologic Oncology Unit of the
Catholic University of Campobasso, complaining of vul-
var burning. Her family history did not reveal malignan-
cies in first-degree relatives, and her past medical
history was unremarkable. At gynaecological examina-
tion vagina, cervix and uterus appeared normal, whereas
an ulcerated area (maximum diameter = 7 cm) involving
the clitoris and both the right and left majus and minus
labium was documented. Inguinal lymphadenopathies
(maximum diameter = 1.5 cm) were bilaterally palpable.
Biopsy of the lesion documented a well differentiated
vulvar squamous cell carcinoma, and staging work-up,
including chest X-rays, and abdominal CT scan, did not
show any sign of distant sites of disease. Radical vulvect-
omy plus bilateral inguinal lymphadenectomy and vulvar
reconstruction using the medial thigh VY advancement
flap was performed. At histology, frank squamous
maturation was particularly represented on tumor
* Correspondence: gabriella.ferrandina@libero.it
1Department of Oncology, Gynaecologic Oncology Unit, Catholic University,
Campobasso, Italy
Full list of author information is available at the end of the article
Petrillo et al. Diagnostic Pathology 2011, 6:95
http://www.diagnosticpathology.org/content/6/1/95
© 2011 Petrillo et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.surface, whereas a gradient of dedifferentiation was
observed toward deeper portions of tumor in which
spindle shaped cells were more evident (Figure 1A, B,
C). Both patterns were more or less represented in pri-
mary tumor (Figure 1A, B, C, D, E), as well as in lymph
node metastases. Panel D and E also showed immuno-
histochemical analysis of high molecular weight cytoker-
atin (Monoclonal Mouse Anti-Human Cytokeratin High
Molecular Weight, clone 34bE12, DAKO, Carpinteria,
CA, USA) and vimentin (DAKO, Carpinteria, CA, USA)
performed using a labeled streptavidin biotin peroxidase
method (Visualization of the reaction was performed
with the DAKO LSAB 2 kit peroxidase). Both squamous
cell carcinoma and sarcomatoid components showed
reactivity for high molecular weight cytokeratins, espe-
cially in the better differentiated areas (Figure 1D);
vimentin highlighted the dense stromal reaction,
whereas tumor cell resulted consistently negative (Figure
1E). Staining for HHF-35 (DAKO, Carpinteria, CA,
USA) and S-100 (DAKO, Carpinteria, CA, USA) was
also documented in areas with sarcomatoid features
(data not shown). Considering the morphological fea-
tures showing the presence of two easily identifiable
epithelial and sarcomatoid components, the apparent
transition from carcinomatous to sarcomatoid areas, as
well as the results of the immunohistochemical analysis
revealing reactivity of giant nucleated cells for cytokera-
tin with negative staining for vimentin, the case was
finally defined as vulvar squamous cell carcinoma with
sarcomatoid features (VSCS). Overall lymph node
metastases were documented in 5 of 47 inguinal lymph
nodes and final staging was pT2N2M0 according to
TNM classification [5]. Surgical margins of resection
appeared uninvolved. Given the occurrence of bilateral
groin wound dehiscence requiring approximately 3
months of intensive wound care for complete resolution,
the original treatment plan including chemotherapy plus
radiation had to be shifted to systemic treatment: con-
sidering the paucity of data about medical treatment of
this neoplasia, a regimen including platinum agents as
well as anthracyclines was chosen given the widely
recognized activity of these two classes of drugs in
epithelial and sarcomatous neoplasia, respectively [2,3].
Considering also age and clinical conditions, the patient
was triaged to the less toxic combination of carboplatin
(AUC 5) and pegylated liposomal doxorubicin (30 mg/
m
2) q21. After completion of 6 cycles of primary treat-
ment, the patient started the routinary follow-up pro-
gram, and only 1 month after the last cycle
gynaecological examination revealed the presence of a
fixed nodule in the left majus labium (maximum dia-
meter = 2.5 cm). Complete surgical excision of the sus-
pected area was carried out and final histology
documented the same phenotypic features of the
primary tumor with squamous cell differentiation as the
largely dominating component (Figure 1F). One month
later, PET-computed tomography showed abnormal
uptake of the radiotracer in the right lung hilar, med-
iastinal, and right obturatory lymph nodes. The patient
was triaged to receive salvage chemotherapy with pacli-
taxel (135 mg/m
2) q21 and consolidation by involved
field stereotactic radiotherapy. Chest/abdominal CT
scan was performed after 4 cycles of chemotherapy doc-
umenting a partial response to treatment with the disap-
pearance of the right obturatory lymphadenopathies and
a significant reduction of the mediastinal (5 mm vs 10
mm as maximum diameter), and right hilar (12 mm vs
19 mm as maximum diameter) lymphadenopathies.
Thereafter, extracranial stereotactic radiotherapy was
planned by the Precise-Plan treatment planning system.
Patient was immobilized using the Stereotactic Body-
Frame (Elekta) and a class solution with 4 non-coplanar
fixed beams based on the tetrad configuration was used
to treat pre-chemotherapy nodal targets. Five consecu-
tive daily fractions were delivered to mediastinal and
right hilar nodes up to a total dose of 45 Gy/9 Gy frac-
tion and to right obturatory lymphadenopaties up to 40
Gy/8 Gy fraction. Treatment was very well tolerated and
obtained a radiological complete response. Two months
later, in January 2011, the patients was admitted to our
Institution complaining of severe asthenia and moderate
dyspnoea. Total body CT scan documented multiple
bilateral pulmunary metastases (maximum diameter = 2
cm), enlarged right iliac lymph nodes (maximum dia-
meter = 2 cm), a focal liver lesion (maximum diameter
= 2 cm), and an ulcerated perineal area infiltrating the
urethra (maximum diameter = 5 cm). The patient died
after 1 month due to acute respiratory failure, after 18
months from initial diagnosis.
Discussion
The histopathological diagnosis of VSCS is usually for-
mulated in presence of two separate components, one
with clinical squamous features generally located on the
tumor surface, and the other one located in the deeper
portions of the tumor characterized by anaplastic sarco-
matoid morphology. Differential diagnosis should also
include vulvar sarcoma, malignant fibrous histiocytoma,
and amelanocitic malignant melanoma [4]. However,
along the diagnostic process, the most difficult problem
is certainly represented by distinguishing VSCS from
malignant mixed Müllerian tumor (MMMT). In this
context, it should be taken into account that the most
common location of MMMT is represented by uterine
corpus followed by cervix and vagina, so that the possi-
bility that vulvar disease could be just a metastatic site
from primary uterine tumor has to be not underesti-
mated. Moreover, the epithelial component of MMMT
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Page 2 of 5Figure 1 Vulvar squamous cell carcinoma with sarcoma-like stroma (A, B, C, D, E tumor features at presentation site; F local tumor
recurrence). A, B. Good squamous differentiation with keratinous pearls at tumor surface (upper-left corner in A and B) and less differentiated,
spindle shaped cells in deeper portions of the tumor (right in A and B). Presence of scattered anaplastic, pseudosarcomatous cancer cells in a
dense reactive stroma is shown in B (hematoxylin and eosin stain). C. At higher magnification ill defined cell borders are better seen
(hematoxylin and eosin stain). D. Tumor cells presented positive for cytokeratins, more in the superficial, better differentiated portion of the
tumor (upper-left corner). Inset shows the presence of reactivity for Cytokeratin in the isolated, giant neoplastic cells (Monoclonal Mouse Anti-
Human Cytokeratin High Molecular Weight, clone 34bE12, DAKO, Carpinteria, CA, USA). E. Vimentin stain highlights a thick reactive vascular
stroma, whereas giant and spindle shaped tumor cells appear negative (central portion of picture) (Dako, Carpinteria, CA, USA). F. Local tumor
recurrence. Note the higher degree of tumor differentiation with abundance of keratinous pearls in this representative histological field
(hematoxylin and eosin stain). Bars are 100 μmi nA ,B ,D ,F ;5 0μm in E and D inset; 25 μmC .
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squamous cells, and is usually intermingled with the sar-
comatous components rather than showing an easily visi-
ble division into superficial versus deeper areas as in
VSCS; another morphological VSCS feature not shared
by MMMT is the apparent transition from carcinoma-
tous to sarcomatoid areas [4]. Although these peculiar
morphological features may be helpful in identifying
VSCS, the formulation of an appropriate diagnosis on the
basis of conventional hematoxylin and eosin stain would
be difficult. In this context, the presence of diffuse immu-
noreactivity for cytokeratin in spindle shaped tumor cells
have been very useful to rule out a mesenchymal tumor
which usually does not show a positive staining for cyto-
keratin. However, it should be taken into account that
some mesenchymal malignancies such as Ewing’ss a r -
coma and epithelioid sarcoma may express cytokeratin so
that it can be helpful to utilize a panel of antibodies,
including anti-vimentin usually expressed in sarcoma
cells. Finally, in our case, as in the one reported by Par-
ham et al. [6], the initial surgical sampling did not allow
to draw a definitive diagnosis, thus suggesting that an
extensive tissue sampling is necessary to formulate a cor-
rect diagnosis of this rare entity.
The histogenesis of VSCS remains to be clarified, but
it is more commonly believed that VSCS might arise
from a metaplastic process of the carcinomatous com-
ponent. In this context, our results showing reactivity of
both squamous cell carcinoma and sarcomatoid compo-
nent for high molecular weight cytokeratin seem to sug-
gest the epithelial origin of the sarcoma-like cells, as
proposed by other authors [3,7]. It remains to be veri-
fied whether this phenomenon could in term hesitate
into the occurrence of what is called epithelial mesench-
ymal transition.
The comparison with other similar cases reported in
t h el i t e r a t u r e( T a b l e1 )i sd i f f i c u l td u et ot h ep a u c i t yo f
series, and the wide heterogeneity of cases relative to
the original definition of histology, and also stage at pre-
sentation, and treatment modalities; as far as clinical
outcome is concerned, with the exception of some cases
diagnosed at early stage disease [3,6] or characterized by
a bizarre continuously changing morphology at recur-
rence [6], the vast majority of cases experienced a
rapidly progressive and fatal disease [4,6-12], despite the
exploitment of multimodal treatment with radical sur-
gery and adjuvant radiotherapy and/or chemotherapy
[12,13].
Table 1 Clinico-pathological characteristics, treatment details, and follow-up status of the previously published cases
of sarcomatoid squamous cell carcinoma of the vulva
Author No.
cases
Age FIGO
Stage
Primary treatment Pathological
Node Status
Histologic Report DFS Overall
Survival
Way [8] 6 - - Surgery n.a. Unusual epithelioma - Less
than 4.5
years
Gosling [9] 2 - - Surgery n.a Spindled squamous
carcinoma
--
Copas [13] 1 54 III Radical vulvectomy with bilateral groin and
pelvic lymphadenectomy followed by adjuvant
CT and RT
+ Poorly differentiated
squamous cell carcinoma
1 month 2-3
months
Steeper [4] 1 89 - RT followed by simple vulvectomy n.a. Pseudosarcomatous
squamous cell carcinoma
8 months 32
months
LiVolsi [10] 2 - - n.a. n.a Carcinoma with
sarcomatoid features
--
Santeusanio
[7]
1 77 IV Radical vulvectomy with bilateral inguinal
lymphadenectomy
+ Carcinoma with
sarcoma-like features
15 days 1 month
Parham [6] 1 54 I Local excision n.a. Mixed soft tissue sarcoma
with atypical squamous
cell
3 years More
than 6
years
Cooper [12] 1 73 III Radical vulvectomy with bilateral inguinal
lymphadenectomy
+ Sarcomatoid squamous
cell carcinoma
5 months -
Choi [3] 1 43 II Local excision with bilateral inguinal
lymphadenectomy
- Sarcomatoid squamous
cell carcinoma
Non
evident
disease
More
than 2
years
Loizzi [11] 1 85 II Radical vulvectomy with center inguinal
lymphadenectomy
- Carcinosarcoma 1 month 2
months
Present case 1 79 III Radical vulvectomy with bilateral inguinal
lymphadenectomy followed by CT
+ Sarcomatoid squamous
cell carcinoma
1 month 18
months
CT: chemotherapy; RT: radiation therapy
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Page 4 of 5Even recognizing that VSCS might have an intrinsic
biological aggressiveness [7], the observation that cases
presenting at diagnosis with early stage disease [3,6]
may experience a very long survival, emphasize the need
to make any effort in order to achieve an early
diagnosis.
As already acknowledged, no specific guidelines for
treatment of VSCS are available, due to its rare occur-
rence. Radical surgery seems to guarantee in some cases
an adequate local control, whereas the role of adjuvant
chemotherapy remains unclear: in our case, a combina-
tion regimen with platinum and anthracyclines, which
a r er e c o g n i z e dt ob ea c t i v ea g a i n s tc a r c i n o m a t o u sa n d
sarcomatous component [14], resulted unsuccessful with
rapid development of local recurrence. On the other
hand, we reported a partial response to taxanes and
even with the disappearance of some sites of metastatic
disease, thus expanding the range of drugs potentially
available against this disease. Radiation therapy was
explored as primary treatment [4], as in the adjuvant
setting [13] with unsatisfying results: however, in our
case disappearance of all metastatic sites was achieved
administering stereotactic radiotherapy [15], suggesting
that, at least in principle these tumors may retain sensi-
tivity to radiotherapy, especially if administered by hypo-
f r a c t i o n a t i o nm o d a l i t y( h i g hd o s e / f r a c t i o ni nas h o r t
overall treatment time) and stereotactic technique.
Overall, our case considering the advanced stage of dis-
ease, showed a relatively longer OS and also an accepta-
ble symptom-free period compared to results from the
available literature, probably due to the use of a multi-
modal therapeutic approach.
Conclusions
The rarity of this entity, the diagnostic difficulties, and
poor survival highlights the need for a systematic collec-
tion of these tumors in order to help pathologists and
gynaecologists to achieve an early diagnosis, and develop
in the next future more effective therapeutic strategies.
In this context, the biological characterization of this
rare neoplasia seems worth while.
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